ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Shionogi in talks with U.S. to supply COVID oral drug

Japanese drugmaker also says vaccine proven effective in trials

Shionogi is set to start clinical trials in the U.S. for its COVID-19 oral therapy.(Nikkei montage/Photos by Tomoki Mera, Shionogi)

OSAKA -- Japanese drugmaker Shionogi & Co. said Friday that it has entered talks with the U.S. government to supply its oral medication for COVID-19 currently in development.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more